Medtronic PLC (MDT)
Return on equity (ROE)
| Apr 30, 2024 | Apr 26, 2024 | Apr 30, 2023 | Apr 28, 2023 | Apr 30, 2022 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 3,676,000 | 3,676,000 | 3,758,000 | 3,758,000 | 5,039,000 |
| Total stockholders’ equity | US$ in thousands | 50,214,000 | 50,214,000 | 51,483,000 | 51,483,000 | 52,551,000 |
| ROE | 7.32% | 7.32% | 7.30% | 7.30% | 9.59% |
April 30, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $3,676,000K ÷ $50,214,000K
= 7.32%
Based on the provided data, Medtronic PLC's return on equity (ROE) has experienced a slight decline over the period analyzed. The ROE decreased from 9.59% in April 2022 to 7.30% in both April 2023 and April 30, 2023, remaining stagnant. However, there was a marginal increase to 7.32% in both April 26, 2024, and April 30, 2024. This fluctuation in ROE could indicate varying levels of profitability and efficiency in generating returns for shareholders during the period under review. Further analysis of the company's financial performance and operational efficiency may be necessary to understand the factors driving these changes in ROE.
Peer comparison
Apr 30, 2024